Genentech’s Gazyva improves renal response in lupus nephritis patients

Micrograph of diffuse proliferative lupus nephritis, which could cause end-stage renal disease and death. Credit: Nephron.



  • Genentech’s Gazyva improves renal response in lupus nephritis patients